Embryonic paratesticular rhabdomyosarcoma: a case report

An embryonic paratesticular rhabdomyosarcoma is a very rare mesenchymal tumor. It is an intrascrotal tumor that is localized in paratesticular structures such as the epididymis or spermatic cord. Rhabdomyosarcoma is most often observed in children and adolescents, presenting as a painless scrotal ma...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical case reports 2013-04, Vol.7 (1), p.93-93, Article 93
Main Authors: Bouchikhi, Ahmed Amine, Mellas, Soufiane, Tazi, Mohammed Fadl, Lahlaidi, Karim, Kharbach, Youssef, Benhayoune, Khadija, Kanab, Rajae, Elammari, Jalal Eddine, Khallouk, Abdelhak, El Fassi, Mohammed Jamal, Farih, My Hassan
Format: Article
Language:English
Subjects:
Care and treatment
Case Report
Case studies
CT imaging
Cyclophosphamide
Diagnosis
Health aspects
Medical research
Medicine, Experimental
Metastasis
Patient outcomes
Rhabdomyosarcoma
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An embryonic paratesticular rhabdomyosarcoma is a very rare mesenchymal tumor. It is an intrascrotal tumor that is localized in paratesticular structures such as the epididymis or spermatic cord. Rhabdomyosarcoma is most often observed in children and adolescents, presenting as a painless scrotal mass. Our patient was an 18-year-old Moroccan man who presented with a painless left scrotal mass that had evolved over four months. An inguinal orchiectomy was performed. A histological examination of the excised tissue revealed an embryonic rhabdomyosarcoma.Our patient had three sessions of chemotherapy with vincristine, actinomycin C and cyclophosphamide. Each chemotherapy session was conducted over five days, with a cycle of 21 days. Our patient was assessed two months after the last chemotherapy session and demonstrated good clinical improvement. Paratesticular rhabdomyosarcoma is a rare aggressive tumor manifesting in children and very young adults. Localized forms have a good prognosis whereas metastatic tumors show very poor results. A well-defined treatment based on surgery and chemotherapy yields good results.
ISSN:1752-1947
1752-1947
DOI:10.1186/1752-1947-7-93